Related Experiment Video

Updated: Aug 22, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Molecular effects of cyclosporine and oncogenesis: a new model

N André1, B Roquelaure, J Conrath

  • 1Pediatric Oncology Department, Children Hospital of "La Timone", Bd Jean Moulin, 13885 Marseille Cedex 5, France. nicolas.andre@ap-hm.fr

Medical Hypotheses
|August 25, 2004
PubMed

Insights

Cyclosporine A, an immunosuppressant, may increase cancer risk not just by weakening immunity but also by promoting DNA mutations and aggressive cancer cell behavior. New strategies are needed to prevent these adverse effects.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Cyclosporine A is a vital immunosuppressant in organ transplantation.
  • A significant concern is the increased incidence of de novo cancers associated with its use.
  • Current understanding attributes this risk primarily to immune suppression.

Purpose of the Study:

  • To explore molecular mechanisms beyond immunosuppression by which Cyclosporine A may contribute to cancer.
  • To propose a multifactorial model for Cyclosporine A-induced oncogenesis.

Main Methods:

  • Review of existing literature on Cyclosporine A's molecular effects.
  • Analysis of pathways including DNA repair, TGF-Beta signaling, and apoptosis regulation.
  • Synthesis of evidence to link molecular effects to cancer development and progression.

Main Results:

  • Cyclosporine A inhibits DNA repair mechanisms, potentially leading to increased mutations.
  • It influences apoptosis pathways, affecting the clearance of potentially cancerous cells.
  • The drug may also promote cancer cell aggressiveness and transformation.

Conclusions:

  • Cyclosporine A's role in cancer genesis is likely multifactorial, involving direct molecular effects beyond immunosuppression.
  • These include facilitating DNA mutations, reducing clearance of altered cells, and enhancing cancer cell aggression.
  • Understanding these mechanisms is crucial for developing novel preventive and therapeutic strategies.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...